Medical Device and Diagnostic Industry (MD+DI)

Developing Good Machine Learning Practices for Generative AI in Medtech

Generative AI in medtech raises questions on safety, validation, and regulatory challenges, explored in MD&M West's "GenMLP" ...
Clinical Trials Arena on MSN

FDA and EMA release collaborative AI framework for drug development

In a bid to optimise the use of AI in drug development, US and European regulators have banded together to advise industry ...
Drug Target Review

AI steps into drug safety: predicting liver injury earlier than ever before

Learn how AI is transforming predictions of drug-induced liver injury and aiding drug development for safer therapeutics.

Phlow and Enveda Partner to Advance AI-Driven Chemistry to Accelerate Domestic Pharmaceutical Development and Transform Drug Substance Manufacturing

In just three months, Phlow and Enveda generated and analyzed nearly 20,000 unique reactions, creating one of the largest high-quality datasets of its kind. The resulting uniform dataset is ...

Converge Bio raises $25M to bring generative AI drug discovery to every biotech and pharmaceutical company

Converge Bio, the AI platform for accelerated drug discovery and development, announced today $25 million in Series A funding, bringing its total raised to $30 million. The round was led by Bessemer ...
Precision Medicine Online

Precede Raises $84M to Integrate Liquid Biopsy Test Alongside Next-Gen Precision Cancer Drugs

The firm is focused on helping pharma characterize response and resistance to their drugs, with the hope of getting a companion diagnostic approval.

What Galapagos Tortoises Can Teach Us About Drug Development

In Darwinian terms, survival isn’t a matter of being the biggest, the fastest, or the strongest of the species, but instead ...
TMCnet

insitro to Acquire CombinAbleAI to Complete its Full Stack, Modality-Agnostic AI Platform for Drug Discovery and Design

AI therapeutics company built on causal biology, today announced the acquisition of CombinAbleAI and the launch of insitro's TherML™ (Therapeutic Machine Learning) platform. The acquisition, which is ...
TMCnet

Lantern Pharma Announces Establishing an A.I. Center of Excellence in India to Industrialize the RADR® Platform and Accelerate Global Development Opportunities with BioPharma ...

Lantern Pharma Inc. (NASDAQ: LTRN), a pioneer in AI-driven precision oncology and computational therapeutic development, today announced the establishment of an A.I. Center of Excellence and Advanced ...
Frontiers

Machine learning-derived cellular senescence index for predicting prognosis and drug sensitivity in patients with renal cell carcinoma

1 Department of Urology, the First Affiliated Hospital of Harbin Medical University, Heilongjiang, Harbin, China 2 Urology ward, Jiangsu Province Geriatric Hospital, Nanjing, Jiangsu, China Cellular ...
Medical Xpress

Accelerating drug combination discovery with machine learning

Discovering effective drug combinations may now be easier thanks to a screening platform made public today by St. Jude Children's Research Hospital scientists. Many diseases, including cancers, ...
Healio

FDA qualifies first AI tool to accelerate MASH drug development

Please provide your email address to receive an email when new articles are posted on . AIM-MASH AI Assist is the first AI drug development tool to be qualified by the FDA. The tool is designed to ...